Nothing to sneeze at: Real-time pollen forecasts

December 22, 2008
Scientists have identified chemical structures in pollen -- shown above covering the face and legs of a Marmelade fly-- that could help provide a real-time pollen detection and warning system to help allergy sufferers. Credit: André Karwath

Researchers in Germany are reporting an advance toward development of technology that could make life easier for millions of people allergic to plant pollen. It could underpin the first automated, real-time systems for identifying specific kinds of allergy-inducing plant pollen circulating in the air. Their study is in the current issue of ACS' Analytical Chemistry.

In the study, Janina Kneipp and colleagues explain that current pollen counts and allergy warnings are based on visual identification of the specific kind of pollen by examining pollen grains under a microscope. That procedure takes time, making it impossible for allergy-sufferers to know the kinds of pollen that are airborne on an hour-by-hour basis.

The researchers describe using a common laboratory procedure to identify chemical structures in pollen grains that distinguish oak and maple pollen, for instance, from maple and other kinds. They obtained these chemical "signatures" for 15 different kinds of tree pollen with the procedure, termed Raman spectroscopy. The researchers say that it could provide the basis for a real-time pollen detection and warning system to help allergy sufferers.

Article: "Chemical Characterization and Classification of Pollen",

Source: ACS

Related Stories

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.